Essen BioScience, Nycomed partner to develop modulators of voltage-gated ion channels

​Essen Bioscience is a Sartorius brand.

Essen BioScience Inc. - a specialty provider of cell-based assay solutions and contract research services - and Nycomed - a privately owned global pharmaceutical company headquartered in Zurich, Switzerland - are pleased to announce a joint discovery agreement to identify novel small molecule ion channel modulators as pain therapeutics.

“We are delighted to forge this partnership with Nycomed. The milestone driven aspect of this collaboration recognizes our team's experience in ion channel drug discovery as well as ion channel technology. To bring this experience in partnership with Nycomed's broader discovery and development capability is exciting.”

Under the terms of the agreement, the two companies will collaborate to screen, optimize and develop modulators of voltage-gated ion channels. Essen BioScience will provide core expertise in ion channel drug discovery, planar array electrophysiology and in vitro profiling. Nycomed will contribute capabilities in medicinal chemistry, drug discovery and development.

Kirk Schroeder, President of Essen BioScience, commented: "We are delighted to forge this partnership with Nycomed. The milestone driven aspect of this collaboration recognizes our team's experience in ion channel drug discovery as well as ion channel technology. To bring this experience in partnership with Nycomed's broader discovery and development capability is exciting."

Sham Nikam, Head Global Discovery at Nycomed, added: "This collaboration with Essen BioScience is a real win-win situation. It significantly strengthens Nycomed's development pipeline and further underlines our strategy to build on partnerships to develop new innovative products."

Financial terms of the agreement were not disclosed.

Source:

Essen BioScience and Nycomed

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Sartorius. (2020, April 01). Essen BioScience, Nycomed partner to develop modulators of voltage-gated ion channels. News-Medical. Retrieved on October 31, 2024 from https://www.news-medical.net/news/20100621/Essen-BioScience-Nycomed-partner-to-develop-modulators-of-voltage-gated-ion-channels.aspx.

  • MLA

    Sartorius. "Essen BioScience, Nycomed partner to develop modulators of voltage-gated ion channels". News-Medical. 31 October 2024. <https://www.news-medical.net/news/20100621/Essen-BioScience-Nycomed-partner-to-develop-modulators-of-voltage-gated-ion-channels.aspx>.

  • Chicago

    Sartorius. "Essen BioScience, Nycomed partner to develop modulators of voltage-gated ion channels". News-Medical. https://www.news-medical.net/news/20100621/Essen-BioScience-Nycomed-partner-to-develop-modulators-of-voltage-gated-ion-channels.aspx. (accessed October 31, 2024).

  • Harvard

    Sartorius. 2020. Essen BioScience, Nycomed partner to develop modulators of voltage-gated ion channels. News-Medical, viewed 31 October 2024, https://www.news-medical.net/news/20100621/Essen-BioScience-Nycomed-partner-to-develop-modulators-of-voltage-gated-ion-channels.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
The New Picus® 2 sets a new standard for connected electronic pipettes